Clinical Study of CAR-T Technique in the Treatment of Recurrent and Refractory Hematopoietic and Lymphatic Tumor

Study Summary

To evaluate the safety of autologous CAR-T cell injection in the treatment of recurrent and refractory hematopoietic and lymphoid tissue tumors

Interventions

Study Locations

Facility	City	State	Country
Cangzhou People's Hospital	Cangzhou	Hebei	China

Official Trial Information

View on ClinicalTrials.gov